abrilumab
Sign in to saveAlso known as AMG 181
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
This drug was developed by MedImmune.
Excerpted from Wikipedia’s “abrilumab” article, available under the CC BY-SA 4.0 licence.